Abstract:Meng Lu Dian-rong Xiu Li-mei Guo Chun-hui Yuan Ling-fu Zhang Lian-yuan Tao 2 1Department of Pulmonary Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, People’s Republic of China; 2Department of General Surgery, Peking University Third Hospital, Beijing, People’s Republic of China; 3Department of Pathology, Peking University Third Hospital, Beijing, People’s Republic of China Background: Pancreatic ductal adenocarcinoma has a devastatingly poor prognosis, and most prognostic factors reflected the tumor stage more than the tumors’ biology. The peripheral nerve plexus is densely distributed in the tumor micro-environment, and there are interactions between tumor cells and these nerves. Perineural invasion is an important risk factor for tumor recurrence and metastasis in pancreatic head adenocarcinoma, but the concrete types of extrapancreatic neuropathy and its role in predicting prognosis are still not clear. Objective: To clarify the role of extrapancreatic neuropathy in the early postoperative liver metastasis and tumor-related mortality in pancreatic head adenocarcinoma and to study the mechanism of tumor recurrence and liver metastasis in pancreatic head adenocarcinoma. Methods: We reported a retrospective study of 60 patients with resectable pancreatic head adenocarcinoma, all of whom accepted radical pancreaticoduodenectomy. Plexus pancreaticus capitalis II (PLX-II) was the representation of extrapancreatic plexus in our study, and all of these plexus had immunohistochemical staining. We defined the postoperative tumor recurrence and tumor-related mortality within 6 months as the early prognostic indicators and analyzed the pathological alterations in PLX-II among different prognosis groups. Results: There were 18 patients suffering early postoperative liver metastasis; these two groups differed significantly in the average number of nerve trunks (P<0.001), the proportion of neuritis (P=0.003), the content of sympathetic nerve fibers (P=0.004) and parasympathetic nerve fibers (P<0.001) per unit area of PLX-II. There were 15 patients suffering early postoperative mortality, and there were significant differences between these two groups in the average number of nerve trunks (P<0.001), the proportion of neuritis (P=0.009), the content of sympathetic nerve fibers (P=0.023) and parasympathetic nerve fibers (P<0.001) per unit area of PLX-II. Conclusion: The patterns of extrapancreatic neuropathy could reflect the biological behavior of resectable pancreatic head adenocarcinoma, and the pathological features of PLX-II were closely related to early liver metastasis and mortality.

The Relationship between Regional Lymph Node Metastases and Expression of P53 and Ki67 in Pancrestic Carcinoma and its Prognostic Significance

Impact of Lymph Node Metastasis on Survival of Patients with Pancreatic Cancer

Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors

Relationship Between Lymph Node Metastases in Colorectal Carcinoma and Immunohistochemical Expression of Tumor Associated Molecular Markers

Effect of the Number of Positive Lymph Nodes and Lymph Node Ratio on Prognosis of Patients after Resection of Pancreatic Adenocarcinoma

Lymph Node Involvement in Pancreatic Neuroendocrine Tumors: Significance As a Predictor of Survival

Prognostic Value of Programmed Cell Death Protein 1 Expression on CD8+ T Lymphocytes in Pancreatic Cancer

Detection of Lymph Node Micrometastasis in Pancreatic Head Carcinoma

Pathologic analysis of lymph node involvement in carcinoma of head of pancreas

Clinico-pathological Characteristics and Influencing Factors of Lymph Node Metastasis of Pancreatic Head Carcinoma

Expression of Vascular Endothelial Growth Factor-C and Vascular Endothelial Growth Factor Receptor-3 Protein in Nymph Nodes of Pancreatic Cancer and Its Clinical Significance

Value of Lymphadenectomy in Patients with Surgically Resected Pancreatic Neuroendocrine Tumors

Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma

Ott_a_221844 11083..11095

The expression of Her-2 in patients with pancreatic carcinoma and its significance

Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors

Negative p53 Expression Confers Worse Prognosis in Patients With Resected Pancreatic Ductal Adenocarcinoma

The relationship between the expression levels of p53 and Ki67 in gastric cancer tissues and the quality of life and clinical prognosis of patients with gastric cancer

Diagnosis of Micrometastasis in Lymph Nodes of Patients with Pancreatic Cacarcinoma by Using Pan CK Staining

Correlations Between P53 Expression and Clinicopathologic Factors and the Prognosis of Luminal Breast Cancer

Clinicopathological Significance of Expression of HIF-1α and P-gp in Pancreatic Carcinoma